{"canonical":"https://abierto.us/opportunities/bardaieidd063025","key":"BARDAIEIDD063025","url":"https://abierto.us/opportunities/bardaieidd063025","title":"Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation","solicitation_number":"BARDA-IEIDD-063025","notice_type":"u","open":false,"response_deadline":null,"first_posted":"2025-06-30","last_posted":"2025-06-30","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE","office":"ASPR BARDA DIV CONTRACTS MGMT & ACQ","naics":"541715","psc":"AN12","set_aside":null,"place_state":"NC","place_county":"37129","place_county_name":"New Hanover County","place_city":"3774440","place_city_name":"Wilmington","winner":"PPD DEVELOPMENT LP","award_amount":null,"publications":[{"notice_id":"f4eb98d18fa441c0b1883cda9980e36f","title":"Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation","solicitation_number":"BARDA-IEIDD-063025","notice_type":"u","base_type":"u","posted":"2025-06-30","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2025-07-30","award_number":"75A50123C00045","awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/f4eb98d18fa441c0b1883cda9980e36f/view","enriched":false,"history":[]}],"latest_notice_id":"f4eb98d18fa441c0b1883cda9980e36f","first_type":"u","notices":[{"award":{"date":"2023-09-29","number":"75A50123C00045"},"dates":{"posted":"2025-06-30","award_date":"2023-09-29"},"links":{"sam":"https://sam.gov/workspace/contract/opp/f4eb98d18fa441c0b1883cda9980e36f/view"},"naics":{"codes":["541715"],"primary":"541715"},"title":"Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation","agency":{"office":{"code":"75ANBA","name":"ASPR BARDA DIV CONTRACTS MGMT & ACQ"},"subtier":{"code":"7505","name":"OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20515","city":"Washington","state":"DC","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-07-30","archive_type":"auto30"},"contacts":[{"name":"Jill Johnson, Contracting Officer","role":"primary","email":"jill.johnson@hhs.gov","phone":"202-816-11484"}],"base_type":{"code":"u","label":"Justification"},"notice_id":"f4eb98d18fa441c0b1883cda9980e36f","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T17:45:50.850439Z","row_sha256":"4cd7f40e27d31563c92833496c53c2d847075c6b01742fc2ffb9b2b9bf502cc8","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T17:45:50.850439Z","first_seen_at":"2026-09-16T17:45:50.850439Z"},"description":{"text":"This procurement is aimed at providing a central laboratory capacity site for analysis of mucosal and serum samples collected from subjects enrolled in multiple USG-sponsored COVID-19 vaccine trials. This action covers efforts to utilize the validated virus neutralization (VN) and binding assays to support these studies. The program goals are: 1. Establish validated VN and binding assays for SARS-CoV-2 emerging variant(s). 2. Test serum samples from human subjects enrolled in clinical trials of COVID-19 vaccine candidates in variant VN and binding antibody assays in compliance with GCLP guidelines.","origin":"extract"},"notice_type":{"code":"u","label":"Justification"},"schema_version":1,"solicitation_number":"BARDA-IEIDD-063025","place_of_performance":{"zip":"28401","state":{"code":"NC"},"country":{"code":"USA"}},"product_service_code":"AN12"}],"due_at":null,"due_date":null,"closes_at":null,"awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7505","sub_name":"OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE","office_key":"o-75ANBA","office_name":"ASPR BARDA DIV CONTRACTS MGMT & ACQ","state":"NC","county":"37129","county_name":"New Hanover County","city":"3774440","city_name":"Wilmington","country":"USA","winner_key":"ZANENSW6C665","amount":null,"linked_awards":1,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"f4eb98d18fa441c0b1883cda9980e36f","description":{"text":"This procurement is aimed at providing a central laboratory capacity site for analysis of mucosal and serum samples collected from subjects enrolled in multiple USG-sponsored COVID-19 vaccine trials. This action covers efforts to utilize the validated virus neutralization (VN) and binding assays to support these studies. The program goals are: 1. Establish validated VN and binding assays for SARS-CoV-2 emerging variant(s). 2. Test serum samples from human subjects enrolled in clinical trials of COVID-19 vaccine candidates in variant VN and binding antibody assays in compliance with GCLP guidelines.","html":null,"origin":"extract"},"contacts":[{"name":"Jill Johnson, Contracting Officer","role":"primary","email":"jill.johnson@hhs.gov","phone":"202-816-11484"}],"place_of_performance":{"zip":"28401","state":{"code":"NC"},"country":{"code":"USA"}},"office_address":{"zip":"20515","city":"Washington","state":"DC","country":"USA"},"naics_codes":["541715"],"award":{"date":"2023-09-29","number":"75A50123C00045"},"attachments":[],"awards":[{"award_key":"CONT_AWD_75A50123C00045_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75A50123C00045_7505_-NONE-_-NONE-/","piid":"75A50123C00045","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"ZANENSW6C665","recipient_name":"PPD DEVELOPMENT LP","recipient_uei":"ZANENSW6C665","recipient_cage":"3FAW2","recipient_city":"WILMINGTON","recipient_state":"NC","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2024-02-29","last_action_date":"2026-08-18","actions":6,"obligated":"0","current_total_value":"126485055.00","potential_total_value":"126485055.00","naics":"541715","psc":"AN12","extent_competed":"NOT COMPETED","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE DEVELOPMENT, ASSESSING IMPACT OF VARIANTS ON VACCINE IMMUNOGENICITY, AND ANALYZ","method":"piid","confidence":"high","evidence":["award number 75A50123C00045 equals the contract number","same sub-agency 7505"],"opportunity_key":null,"opportunity_title":null}],"related":[]}